Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:9 Issue:2 Number:12 ISSN#:2563-5476
RCT
ACE Report #12145
Ace Report Cover Trauma

Romosozumab has no impact on radiographic or clinical outcomes following hip fracture ORIF


How to Cite

OrthoEvidence. Romosozumab has no impact on radiographic or clinical outcomes following hip fracture ORIF. ACE Report. 2020;9(2):12. Available from: https://myorthoevidene.com/AceReport/Report/12145

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures

J Bone Joint Surg Am.2020

Contributing Authors: EH Schemitsch T Miclau T Karachalios LL Nowak P Sancheti RW Poolman J Caminis N Daizadeh RE Dent-Acosta O Egbuna A Chines J Maddox A Grauer M Bhandari

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Hip fractures are one of the leading causes of disability worldwide, and continue to grow in numbers given the aging global population. When hip fractures are repaired with open reduction, internal fixation, there is concern about the bone quality and healing potential in this population. Thus, numerous different therapies have been investigated recently in an effort to promote bone healing in thi...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.